Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.
AlphaCentric LifeSci Healthcare I LYFIX Fund Analysis
Morningstar’s Analysis LYFIX
Will LYFIX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar